01 1Aurobindo Pharma Limited
02 1Divi's Laboratories Limited
03 1HETERO DRUGS LIMITED
04 2Hetero Drugs Limited
05 1Maithri Drugs Private Limited
06 1Mylan Laboratories Limited
07 1Siegfried Evionnaz SA
01 1RALTEGRAVIR POTASSIUM
02 2Raltegravir
03 4Raltegravir Potassium
04 1raltegravir potassium
01 6India
02 1Switzerland
03 1U.S.A
NDC Package Code : 59651-924
Start Marketing Date : 2023-12-29
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (50kg/50kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 62331-055
Start Marketing Date : 2008-05-28
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 65977-0129
Start Marketing Date : 2007-10-12
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 65977-0158
Start Marketing Date : 2007-10-12
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 65977-0049
Start Marketing Date : 2001-10-12
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 70600-028
Start Marketing Date : 2021-06-15
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 17381-749
Start Marketing Date : 2016-05-23
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 65015-841
Start Marketing Date : 2015-01-12
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
A Raltegravir Potassium manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Raltegravir Potassium, including repackagers and relabelers. The FDA regulates Raltegravir Potassium manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Raltegravir Potassium API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Raltegravir Potassium manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Raltegravir Potassium supplier is an individual or a company that provides Raltegravir Potassium active pharmaceutical ingredient (API) or Raltegravir Potassium finished formulations upon request. The Raltegravir Potassium suppliers may include Raltegravir Potassium API manufacturers, exporters, distributors and traders.
click here to find a list of Raltegravir Potassium suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Raltegravir Potassium as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Raltegravir Potassium API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Raltegravir Potassium as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Raltegravir Potassium and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Raltegravir Potassium NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Raltegravir Potassium suppliers with NDC on PharmaCompass.
We have 6 companies offering Raltegravir Potassium
Get in contact with the supplier of your choice:
LOOKING FOR A SUPPLIER?
